Related Experiment Video
Updated: Jul 8, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Addressing racial differences in the management of atrial fibrillation: Focus on black patients
Hakeem Ayinde1, Favour Markson2, Ugonna Kevin Ogbenna3
1Cardiology Associates of Fredericksburg, Fredericksburg, VA, USA.
Insights
Black patients experience worse outcomes with atrial fibrillation (AF), despite lower prevalence. Addressing disparities in AF care is crucial for improving health equity and patient results.
Area of Science:
- Cardiology
- Public Health
- Health Disparities
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia impacting millions, significantly reducing quality of life and increasing risks of stroke, heart failure, and mortality.
- While Black patients exhibit lower AF prevalence compared to White patients, they disproportionately face severe outcomes and complications from the condition.
Purpose of the Study:
- To highlight the significant disease burden and existing management gaps in Black patients with atrial fibrillation.
- To emphasize the need for stakeholders to recognize and address the inequities in AF care experienced by the Black population.
Main Methods:
- This study is a review of existing literature and epidemiological data on atrial fibrillation prevalence, outcomes, and treatment disparities.
- Analysis focuses on comparing AF-related health outcomes and healthcare access between Black and White patient populations in the United States.
Main Results:
- Black patients with AF demonstrate a higher likelihood of experiencing adverse outcomes, including increased mortality and complications, compared to White patients.
- Identified management gaps include delayed diagnosis, suboptimal risk factor control, and limited access to specialized cardiovascular care for Black individuals with AF.
Conclusions:
- Urgent attention is required to address the disproportionate burden of atrial fibrillation and associated negative outcomes among Black patients.
- Implementing targeted interventions, such as aggressive risk factor management, timely specialist referrals, and enhanced healthcare access, can help mitigate these disparities and improve patient outcomes.
Abstract:
Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting between 3 and 6 million people in the United States. It is associated with a reduced quality of life and increased risk of stroke, cognitive decline, heart failure and death. Black patients have a lower prevalence of AF than White patients but are more likely to suffer worse outcomes with the disease. It is important that stakeholders understand the disproportionate burden of disease and management gaps that exists among Black patients living with AF. Appropriate treatments, including aggressive risk factor control, early referral to cardiovascular specialists and improving healthcare access may bridge some of the gaps in management and improve outcomes.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

